AngioDynamics Inc (STU:UG2)
€ 5.75 0.1 (1.77%) Market Cap: 233.35 Mil Enterprise Value: 184.55 Mil PE Ratio: 0 PB Ratio: 1.17 GF Score: 58/100

AngioDynamics Inc at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 08:20PM GMT
Release Date Price: €19.05 (-0.21%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

(technical difficulty)

As well as Michael Greiner, who is the Chief Financial Officer.

So with that, we're going to have some slides that Jim is going to run through, and then we'll move into a little bit of a Q&A session. So without further ado, Jim?

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

Great. Thank you, Kristen, and thank you to Barclays. Thanks for the invitation to the conference. Again, my name is Jim Clemmer. I joined AngioDynamics nearly 3 years ago. I've spent nearly 30 years in the medical device industry, and I'll take the next few minutes and walk you through a bit about AngioDynamics that you may not know.

First, as you know, today, the words I'm going to say may not come true. So these are forward-looking statements we'll give you. We'll do the best of our ability to predict outcomes, but this is a tough business, and you guys are smart investors. So you'll know to take what we say with a breath of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot